Abstract | BACKGROUND: METHODS: The primary endpoint was to evaluate the frequency of dose-limiting toxicity and determine the maximum-tolerated dose of zinostatin stimalamer when used by intra-arterial infusion. The candidates for this study were patients with hepatocellular carcinoma no longer amenable to established forms of treatment. Hepatic arterial infusion chemotherapy was performed by selectively introducing a catheter into the hepatic artery with zinostatin stimalamer alone. Treatment was repeated at 4-8-week intervals until disease progression or the appearance of unacceptable toxicity. The starting dose of zinostatin stimalamer was 3 mg/m(2), and doses were increased in 1 mg/m(2) increments in successive cohorts. At least three patients were treated at each dose level and three additional patients were treated in the presence of dose-limiting toxicity. RESULTS: Twelve patients were entered into this trial. Dose-limiting toxicity was observed in one of six patients at 3 mg/m(2), and in two of six patients at 4 mg/m(2). The maximum-tolerated dose was judged to be 3 mg/m(2) with liver dysfunction and serum creatinine increase as the dose-limiting toxicity. There was one early death suggested to be related to the protocol treatment. None of the 12 patients achieved an objective tumor response. CONCLUSION:
|
Authors | Hiroshi Ishii, Junji Furuse, Michitaka Nagase, Yasushi Maru, Masahiro Yoshino, Takayuki Hayashi |
Journal | Japanese journal of clinical oncology
(Jpn J Clin Oncol)
Vol. 33
Issue 11
Pg. 570-3
(Nov 2003)
ISSN: 0368-2811 [Print] England |
PMID | 14711981
(Publication Type: Clinical Trial, Clinical Trial, Phase I, Journal Article)
|
Chemical References |
- Antineoplastic Agents
- Maleic Anhydrides
- Polystyrenes
- poly(maleic acid-styrene)neocarzinostatin
- Iodized Oil
- Zinostatin
|
Topics |
- Aged
- Antineoplastic Agents
(administration & dosage)
- Carcinoma, Hepatocellular
(drug therapy)
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Hepatic Artery
- Humans
- Infusions, Intra-Arterial
- Iodized Oil
(administration & dosage)
- Liver Neoplasms
(drug therapy)
- Male
- Maleic Anhydrides
(administration & dosage)
- Middle Aged
- Polystyrenes
(administration & dosage)
- Zinostatin
(administration & dosage, analogs & derivatives)
|